Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit): Triple-Action Regenerative Peptide Complex

The Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) is a high-potency, multi-target research peptide complex engineered for comprehensive musculoskeletal repair, soft tissue regeneration, and extracellular matrix ($\text{ECM}$) remodeling. Combining three bio-active peptides—BPC-157 (Body Protection Compound-157, 10mg), TB4 (Thymosin Beta-4, 10mg), and Cartalax (Cartilage Tripeptide $\text{Ala-Glu-Asp}$, 10mg)—this 30mg total per vial formulation provides a potent synergistic triad designed to accelerate angiogenesis, cellular migration, cartilage synthesis, and connective tissue repair in preclinical research models. Sourcing Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) provides orthopathic researchers, tissue engineers, and cell biologists with an advanced multi-modal reagent for investigating soft tissue, tendon, ligament, and articular chondrocyte repair cascades.

In musculoskeletal repair bioassays, combining BPC-157, TB4, and Cartalax targets distinct yet complementary levels of the regenerative cascade:

• BPC-157 (10mg): A pentadecapeptide ($\text{Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val}$) that upregulates vascular endothelial growth factor ($\text{VEGF}$) receptor expression ($\text{VEGFR2}$) and activates the focal adhesion kinase ($\text{FAK}$)-paxillin pathway to promote rapid angiogenesis, outgrowth, and tendon-to-bone healing.

• Thymosin Beta-4 / TB4 (10mg): A 43-amino-acid peptide that sequester G-actin monomers to regulate actin cytoskeleton dynamics. TB4 drives endothelial and progenitor cell migration, cell survival, and tissue remodeling while mitigating localized fibrotic scar formation.

• Cartalax (10mg): A bioregulatory tripeptide ($\text{H-Ala-Glu-Asp-OH}$) specifically targeted to cartilage tissue. Cartalax regulates protein synthesis in chondrocytes, stimulates collagen type II and aggrecan expression, and protects joint cartilage from inflammatory degradation.

The Deadpool Blend BPC-157/TB4/Cartalax 10mg/10mg/10mg (10 vials/kit) delivers a total payload of 300mg active peptide material (30mg combined active per vial across 10 vials). Lyophilized under sterile vacuum conditions into a highly stable white powder cake, this multi-vial format ensures optimal stoichiometric preservation, protecting fragile peptide chains from hydrolytic cleavage and thermal degradation prior to experimental reconstitution.

Triple-Action Synergistic Dynamics & Technical Specifications

The research utility of the Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) stems from the integrated biological cross-talk of its three constituent active peptides:

• Multi-Tissue Angiogenesis & Cell Migration: BPC-157 upregulates $\text{VEGFR2}$ expression while TB4 mobilizes endothelial cell migration, creating new capillary networks in avascular or injured tissues.

• Cartilage Regeneration & Chondrocyte Protection: Cartalax penetrates articular cartilage matrix to upregulate aggrecan and collagen II transcription, counteracting degenerative cartilage turnover.

• Tendon, Ligament & Fascial Repair: BPC-157 and TB4 accelerate fibroblast proliferation, collagen cross-linking, and focal adhesion dynamics, significantly increasing tensile strength in healing connective tissue.

• Anti-Fibrotic & Anti-Inflammatory Signaling: Downregulates pro-inflammatory nuclear factor-$\kappa\text{B}$ ($\text{NF-}\kappa\text{B}$) cascades and modulates $\text{TGF-}\beta$ signaling to suppress fibrotic scar deposition in damaged tissue beds.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure exact stoichiometric ratios and absolute purity.

Reconstitution Protocols, Laboratory Storage Standards, and Quality Controls

Achieving reproducible, publication-grade results when working with the Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) requires strict adherence to standardized aseptic reconstitution and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Deadpool Blend vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 to 3 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake violently, as high-shear agitation can shear peptide bonds and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of the Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0% and exact stoichiometric balance, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms theoretical mass profiles for all three peptide species. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. The Deadpool Blend BPC-157/TB4/Cartalax (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.